Charles P. Venditti
- Clinical Biochemistry top 0.1%
- Metabolism and Genetic Disorders 55
- Rheumatology top 1%
- Folate and B Vitamins Research 24
- Hematology top 2%
- Genetics top 2%
- Virus-based gene therapy research 24
- Genetics top 2%
- Virus-based gene therapy research 24
-
- Mitochondrial Function and Pathology 21
- CRISPR and Genetic Engineering 11
- Porphyrin Metabolism and Disorders 6
- Biochemical and Molecular Research 6
-
- Neonatal Health and Biochemistry 10
- Co-authors
- Randy J. ChandlerNuria CarrilloIrini ManoliJennifer L. SloanJamie L. FraserMichael J. ChorneyLawrence P. WackettChristopher T. Walsh
- Journals
- Journal of Inherited Metabolic Disease (11 papers)Molecular Genetics and Metabolism (10 papers)Human Gene Therapy (8 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Charles P. Venditti
99 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 130
- Clinical Biochemistry 1.6k
- Rheumatology 891
- Hematology 496
- Genetics 436
- Genetics 1.1k
Countries citing papers authored by Charles P. Venditti
This map shows the geographic impact of Charles P. Venditti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles P. Venditti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles P. Venditti more than expected).
Fields of papers citing papers by Charles P. Venditti
This network shows the impact of papers produced by Charles P. Venditti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles P. Venditti. The network helps show where Charles P. Venditti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles P. Venditti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 30 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 13 | |
| 6 | 2020 | 35 | |
| 7 | 2020 | 33 | |
| 8 | 2019 | 30 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 11 | |
| 11 | 2016 | 52 | |
| 12 | 2016 | 79 | |
| 13 | 2016 | 25 | |
| 14 | 2016 | 59 | |
| 15 | 2015 | 28 | |
| 16 | 2015 | 15 | |
| 17 | 2013 | 30 | |
| 18 | 2012 | 23 | |
| 19 | 2010 | 43 | |
| 20 | 1993 | 37 |
About Charles P. Venditti
Charles P. Venditti is a scholar working on Clinical Biochemistry, Rheumatology and Genetics, having authored 102 papers that have together received 4.1k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (55 papers), Virus-based gene therapy research (24 papers), Folate and B Vitamins Research (24 papers), Mitochondrial Function and Pathology (21 papers), CRISPR and Genetic Engineering (11 papers), Neonatal Health and Biochemistry (10 papers), Porphyrin Metabolism and Disorders (6 papers) and Biochemical and Molecular Research (6 papers). The work is most often cited by research in Clinical Biochemistry (1.6k citations), Rheumatology (891 citations) and Hematology (496 citations). Charles P. Venditti has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Randy J. Chandler, Nuria Carrillo, Irini Manoli, Jennifer L. Sloan, Jamie L. Fraser, Michael J. Chorney, Lawrence P. Wackett, Christopher T. Walsh, Mark S. Sands and Victoria Hoffmann. Their work appears in journals such as Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, Human Gene Therapy, Molecular Therapy — Methods & Clinical Development and Genetics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.